Viamet Pharmaceuticals (Intellectual properties) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Viamet Pharmaceuticals (Intellectual properties) General Information
Description
A set of assets and intellectual property rights related to certain novel aldosterone synthase inhibitors. It consists of development, manufacturing and commercialization of compound named PB6440 used in the treatment of hypertension.
Contact Information
Corporate Office
- Durham, NC
- United States
Corporate Office
- Durham, NC
- United States
Viamet Pharmaceuticals (Intellectual properties) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Viamet Pharmaceuticals (Intellectual properties) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Viamet Pharmaceuticals (Intellectual properties) FAQs
-
Where is Viamet Pharmaceuticals (Intellectual properties) headquartered?
Viamet Pharmaceuticals (Intellectual properties) is headquartered in Durham, NC.
-
What industry is Viamet Pharmaceuticals (Intellectual properties) in?
Viamet Pharmaceuticals (Intellectual properties)’s primary industry is Buildings and Property.
-
Is Viamet Pharmaceuticals (Intellectual properties) a private or public company?
Viamet Pharmaceuticals (Intellectual properties) is a Private company.
-
What is the current valuation of Viamet Pharmaceuticals (Intellectual properties)?
The current valuation of Viamet Pharmaceuticals (Intellectual properties) is .
-
What is Viamet Pharmaceuticals (Intellectual properties)’s current revenue?
The current revenue for Viamet Pharmaceuticals (Intellectual properties) is .
-
Who are Viamet Pharmaceuticals (Intellectual properties)’s investors?
Viamet Pharmaceuticals Holdings has invested in Viamet Pharmaceuticals (Intellectual properties).
-
When was Viamet Pharmaceuticals (Intellectual properties) acquired?
Viamet Pharmaceuticals (Intellectual properties) was acquired on 13-Jan-2020.
-
Who acquired Viamet Pharmaceuticals (Intellectual properties)?
Viamet Pharmaceuticals (Intellectual properties) was acquired by PhaseBio Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
